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BACKGROUND/OBJECTIVES: The level of serum albumin is an index of nourishment care and management. However, the distribution 
and correlates of serum albumin levels among individuals with motor disorders have not been reported until now. Therefore, 
we examined the distribution and correlates of serum albumin levels among individuals with motor disorders.
SUBJECTS/METHODS: A cross-sectional study on 249 individuals with motor disabilities (144 men, mean age: 51.4 years; 105 
women, mean age: 51.4 years) was conducted at five institutions in Ibaraki Prefecture, Japan in 2008. The results were compared 
with data from the National Health and Nutrition Survey.
RESULTS: The mean serum albumin levels were 4.0 ± 0.4 g/dL for men and 3.8 ± 0.5 g/dL for women. Overall, 17 (11.8%) men 
and 25 (23.8%) women had hypoalbuminemia (serum albumin level ≤ 3.5 g/dL); these proportions were greater than those 
among healthy Japanese adults (≤ 1%). Low serum albumin level was related with female sex, older age, low calf circumference, 
low relative daily energy intake, low hemoglobin (Hb), low blood platelet count, low high-density lipoprotein cholesterol (HDL-C), 
low HbA1c, and high C-reactive protein (CRP) levels. The strongest correlates, based on standardized betas, were Hb (0.321), 
CRP (-0.279), and HDL-C (0.279) levels.
CONCLUSIONS: These results indicate that the prevalence of hypoalbuminemia is higher in individuals with motor disabilities 
than in healthy individuals and that inflammation is a strong negative correlate of serum albumin levels. Therefore, inflammation 
should be examined for the assessment of hypoalbuminemia among institutionalized individuals with motor disabilities. 
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INTRODUCTION8)
Motor disability (MD) is commonly defined as the partial or 
entire loss of function of a body part. This frequently results 
in poor stamina, muscle weakness, lack of muscle control, or 
total paralysis. MD is commonly noticeable in neurological 
conditions such as cerebral palsy (CP) and stroke [1]. Individuals 
with MD often demonstrate abnormal feeding behaviors, 
leading to reduced food consumption and malnutrition [2-8]. 
Malnutrition is commonly reported in studies on neurologically 
impaired children (including those with CP) and is related with 
inadequate caloric intake, altered nutrient requirements, impaired 
self-feeding, oral motor dysfunction [3-5], and overall gross 
motor function [9]. Malnutrition is also common in individuals 
who have experienced stroke [6-8], in which case poor food 
and fluid intake may result from swallowing difficulties or other 
stroke-related physical and functional problems [7]. Weight loss 
frequently occurs in individuals with CP or stroke and is an 
important nutritional problem [10,11]. Furthermore, the routine 
determination of weight changes is among the basic criteria 
for individuals undergoing long-term care established by the 
US Joint Commission on Accreditation of Healthcare Organization 
[12]. Weight loss of ≥ 5% in the elderly is associated with a 
relative risk of mortality of 2.2 [13]. 
Albumin is a comparatively small protein synthesized by liver 
cells and is negatively charged. It accounts for about 70% of 
plasma colloid osmotic pressure and is the most profuse protein 
in extracellular fluids. Albumin also plays a critical role in 
regulating fluid distribution in the body [14]. Due to its relatively 
long half-life of approximately 14-20 days, albumin is considered 
a marker of chronic nutritional status [15]. Low albumin 
concentration has been used as a marker of malnutrition [16] 
and is the principal nutritional marker in hospitalized patients 
with chronic kidney disease [17], inflammatory disorders [17,18], 
chronic infection [18], or burns [19]. It is also related with poor 
functional status in older persons [20,21] and is predictive of 
a greater decline in functional status [22].
We previously reported low prevalence (1.3%) of hypoalbumi-
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nemia (serum albumin level ≤ 3.5 g/dL) among individuals with 
intellectual disabilities (ID) as well as an association between 
low serum albumin and both inflammation and medication [23]. 
However, no studies have examined the distributions and 
correlates of serum albumin levels in institutionalized individuals 
with MD. Since individuals with MD are mildly to moderately 
affected by physical disabilities [9,11] as well as problems with 
oral motor function and feeding, which can also affect nutritional 
status [2-8], serum albumin levels may be lower than in healthy 
individuals. Furthermore, onset of MD is widely distributed from 
the early stage of life (prenatal period, perinatal period, infancy) 
to adulthood. Earlier onset could extend the length of time with 
dysphagia and therefore affect serum albumin levels.
In this study, we carried out cross-sectional research on 
institutionalized individuals with MD to examine serum albumin 
levels (particularly the prevalence of hypoalbuminemia), correla-
tion of inflammation, medication, and other variables with low 
serum albumin levels, as well as differences in serum albumin 
levels according to timing of MD onset. 
SUBJECTS AND METHODS
Study subjects
This multi-institutional, cross-sectional research was conducted 
at five support facilities for individuals with MD (Aiseien, Arisu 
No Mori, Ikoi, Sakuraen, and Yukarinosato) in Ibaraki Prefecture. 
This region of Japan is located 109 km north of Tokyo and 
consists of a population around 3 million. In 2008, 7,149 residents 
(approximately 1,000 living in support faculties) from the 
prefecture were identified as having a physical disability. Of 
these, MD was detected in 3,406 individuals. Of the 261 
residents at the five support facilities in this study, 11 individuals 
without any MD (e.g., visual impairment) and one individual 
who was hospitalized during this study were excluded, resulting 
in 249 individuals in the analyses. The research protocol was 
approved by the Institutional Review Board at Ibaraki Christian 
University, with which the first author (HO) was affiliated at the 
time this study was conducted. The ethical approval number 
is 07-10.
In Japan, regular health check-ups for individuals with MD 
are conducted at disability support facilities; these are nearly 
identical to healthy adult check-ups [24]. Anthropometric 
measurements, calculation of relative intakes of energy and 
protein, and blood testing were conducted prospectively from 
September to November 2008. Data on disability, primary 
diagnosis, and medication were collected retrospectively from 
medical records. Onset of MD was classified as early stage (e.g., 
CP, spina bifida) or adulthood and later (e.g., stroke, brain 
contusion) based on the primary diagnosis. 
Anthropometric measurements 
Height, weight, triceps skinfold thickness (TSF), mid-arm 
circumference (MAC), and calf circumference were measured by 
a trained staff member according to standard procedures [25]. 
Mid-arm muscle circumference (MAMC) was calculated using 
the following equation: MAC (cm) - 3.14 × TSF (mm). Mid-arm 
muscle area (MAMA) was calculated using the following equation: 
[MAC (cm) - 3.14 × TSF (mm)]2/(4 × 3.14). Rates of weight change 
were calculated using the weights recorded at each facility x 
(x: 1, 3, or 6) months ago using the following equation: [(weight 
x months ago - current weight)/weight x months ago] × 100%.
Daily food intake
Rate of meal consumption was calculated using the following 
equation: [(food provided - food leftover)/food provided] x 
100%. This rate was multiplied by the energy and protein (per 
kg) of each meal provided by each facility’s national registered 
dietitian for each target individual; average daily values for 
relative intakes of energy and protein (per kg) were calculated. 
Analysis of blood components
Fasting blood samples were collected in the early morning 
and analyzed for red blood cells [RBC, sheath flow direct current 
(DC)] [26], white blood cells (WBC, flow cytometry method) [27], 
serum hemoglobin (Hb, sodium lauryl sulfate-Hb) [28], hematocrit 
(Ht, red blood cell pulse height detection method) [29], blood 
platelet count (PLT, sheath flow DC) [30], total protein (TP, biuret 
method) [31], serum albumin (bromocresol green) [32], aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), and γ
-glutamyl transpeptidase (γ-GTP, Japan Society of Clinical 
Chemistry transferable method) [33], serum total cholesterol 
(TC, enzyme method) [34], triglycerides (TG, enzyme method) 
[34], high-density lipoprotein cholesterol (HDL-C, direct method) 
[35], low-density lipoprotein cholesterol (LDL-C, enzyme 
method) [34], and HbA1c (latex photometric immunoassay) [36]. 
Based on findings from previous studies, inflammation markers 
[C-reactive protein (CRP, latex turbidimetric immunoassay)] [37], 
medications [major and minor tranquilizers, anticonvulsants, 
and others (i.e., gastrointestinal medications, medications for 
the common cold, cardiovascular drugs)], and immunoglobulin 
G (IgG, turbidimetric immunoassay) [38] were also analyzed. 
Frequency of hypoalbuminemia
In Japan, specified albumin levels are used for assessment 
of malnutrition risks among the elderly (> 65 years old): low 
risk, ≥ 3.6 g/dL; medium risk, 3.0-3.5 g/dL; high risk, < 3.0 g/dL 
[39]. Using these criteria, frequency of hypoalbuminemia was 
determined by sex and age in individuals with MD, and the 
results were compared with levels in healthy individuals as 
reported in the annual nationwide National Health and Nutrition 
Survey (NHNS) in Japan (2008) [40]. A total of 30,135 participants 
in the NHNS were selected from among approximately 3,838 
households and household members using stratified random 
sampling. Physical condition, nutritional intake status, and daily 
living habits were analyzed by sex and age cohorts made public 
by the Ministry of Health, Labor, and Welfare. During the NHNS, 
blood tests were conducted for 4,451 people (1,819 men, 2,632 
women) > 20 years old. Matching of participants in the NHNS 
with subjects in the present study was not possible. Therefore, 
the frequencies and mean serum albumin levels for each sex 
and age group (20-29, 30-39, 40-49, 50-59, 60-69, and ≥ 70 
years) were used as a reference.
Statistical analysis
Skewed data (CRP) were log-transformed before analyses. Sex 
and timing of disability onset were used as binary variables. 
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Age (yrs) 51.4 ± 12.21) 51.4 ± 12.3 0.992)
Height (cm) 160.7 ± 9.3 150.5 ± 8.8 < 0.0012)
Weight (kg) 51.4 ± 11.3 46.6 ± 11.6 0.0012)
Body mass index (kg/m2) 19.8 ± 3.8 20.6 ± 4.9 0.172)
Mid-arm muscle circumference (cm) 21.4 ± 3.9 20.0 ± 4.0 0.0042)
Mid-arm muscle area (cm2) 37.7 ± 12.2 33.0 ± 11.6 0.0022)
Relative daily energy intake (kcal/kg) 26.4 ± 8.7 25.2 ± 9.1 0.342)
Relative daily protein intake (g/kg) 1.1 ± 0.3 1.1 ± 0.4 0.392)
Serum albumin (g/dL) 4.0 ± 0.4 3.8 ± 0.5 0.012)
Red blood cells (× 106/μL) 4.4 ± 0.6 4.4 ± 3.4 0.952)
White blood cells (× 103/μL) 6.1 ± 1.9 6.1 ± 2.1 0.932)
Hemoglobin (g/dL) 13.6 ± 1.7 12.1 ± 1.7 < 0.0012)
Total protein (g/dL)  7.0 ± 0.7 6.9 ± 0.6 0.082)
AST (IU/L) 21.2 ± 9.3 19.2 ± 7.3 0.082)
ALT (IU/L) 22.8 ± 15.0 15.0 ± 9.2 < 0.0012)
γ-GTP (IU/L) 43.0 ± 37.3 34.5 ± 34.6 0.072)
Total cholesterol (mg/dL) 165.9 ± 31.7 187.1 ± 36.3 < 0.0012)
HDL cholesterol (mg/dL) 48.8 ± 14.4 53.5 ± 14.4 0.012)
LDL cholesterol (mg/dL) 97.3 ± 28.0 110.1 ± 28.8 0.0012)
Immunoglobulin G (mg/dL) 1,422.7 ± 382.4 1,407.3 ± 374.2 0.752)
C-reactive protein (mg/dL) 
(raw data)
0.95 ± 2.81 0.66 ± 1.62 0.342)
Log C-reactive protein (mg/dL) -0.69 ± 0.72 -0.86 ± 0.74 0.072)
Cases using certain medications (n) 137 (95.1%) 97 (92.4%) 0.373)
ALT, alanine aminotransferase; AST, aspartate transaminase; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; γ-GTP, gamma-glutamyl transpeptidase.
1) Mean ± SD or n (%)
2) T-test, 3) χ2-test.
Table 1. Characteristics of 249 individuals with motor disabilities at five 
institutions in Ibaraki, Japan




































n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Male
Total 144 (100.0)   8 (100.0) 21 (100.0) 27 (100.0) 43 (100.0) 38 (100.0)  7 (100.0)
< 3.0 g/dL2)   3 (0.0) (0.0)   0 (0.0) (0.0)  0 (0.0) (0.0)  1 (3.7) (0.0)  1 (2.3) (0.0)  1 (2.6) (0.0)  0 (0.0) (0.3)
3.0-3.5 g/dL2)  14 (12.5) (1.0)   1 (12.5) (0.0)  2 (9.5) (0.0)  2 (7.4) (0.0)  4 (9.3) (0.3)  5 (13.2) (0.2)  0 (0.0) (2.8)
≥ 3.6 g/dL2) 127 (88.2) (99.0)   7 (87.5) (100.0) 19 (90.5) (100.0) 24 (88.9) (100.0) 38 (88.4) (99.7) 32 (84.2) (99.8)  7 (100) (96.9)
Female
Total 105 (100.0)   3 (100.0) 15 (100.0) 31 (100.0) 26 (100.0) 23 (100.0)  8 (100.0)
< 3.0 g/dL2)   4 (3.8) (0.0)   0 (0.0) (0.0)  2 (13.3) (0.0)  0 (0.0) (0.0)  0 (0.0) (0.0)  1 (4.3) (0.2)  1 (12.5) (0.0)
3.0-3.5 g/dL2)  21 (20.0) (0.4)   0 (0.0) (0.7)  1 (6.7) (0.9)  4 (12.9) (0.0)  8 (30.8) (0.2)  7 (30.4) (0.2)  1 (12.5) (0.6)
≥ 3.6 g/dL2)  80 (76.2) (99.6)   3 (100.0) (99.3) 11 (78.6) (99.1) 27 (87.1) (100.0) 18 (69.2) (99.8) 15 (65.2) (99.6)  6 (75.0) (99.4)
1) Reference: The National Health and Nutrition Survey for healthy individuals, 2008 [40]
2) In Japan, the following indicators are used to assess the malnutrition risk level among the elderly: low risk, ≥ 3.6 g/dL; medium risk, 3.0-3.5 g/dL; high risk, < 3.0 g/dL [39].
Table 2. Serum albumin levels among 249 individuals with motor disabilities at five institutions in Ibaraki, Japan
Continuous variables are reported as mean ± standard deviation 
(SD) or median (range). Effect size was used to determine the 
magnitude of the difference in serum albumin levels between 
individuals with MD and healthy individuals in the NHNS. The 
serum albumin levels among individuals with MD were placed 
into three categories: ≥ 3.6 g/dL, 3.0-3.5 g/dL, and < 3.0 g/dL. 
The distributions of individuals within these three categories 
were compared between individuals with MD and healthy 
individuals in the NHNS. Using sex- and age-adjusted analyses, 
correlation coefficients were calculated to examine associations 
between serum albumin levels and each of the following 
variables: weight, body mass index (BMI), weight change ratio, 
TSF, MAC, MAMC, MAMA, calf circumference, relative daily 
energy intake, relative daily protein intake, WBC, RBC, Hb, Ht, 
PLT, TP, AST, ALT, γ-GTP, TC, HDL-C, LDL-C, TG, HbA1c, CRP, IgG, 
medication use (anticonvulsants and/or major and minor 
tranquilizers, others), and timing of disability onset (binary). 
Significant variables (P < 0.05) were used in multivariable 
analyses using the forced entry method with serum albumin 
level as the dependent variable and sex, age, BMI, MAMA, calf 
circumference, relative daily energy intake, Hb, PLT, HDL-C, 
LDL-C, HbA1c, log CRP, IgG, medication use, timing of disability 
onset, and facilities as dummy variables. Facility 1 was used as 
a reference, and four dummy variables were created for 
Facilities 2 through 5. Ht and MAMC were excluded due to the 
high cross correlation with Hb and MAMA, respectively. TP and 
TC were excluded due to containing serum albumin and HDL-C, 
respectively. Based on the Youden index, the cut-off value in 
the receiver operating characteristic (ROC) curve was determined 
as the point at which the value determined by the formula 
(sensitivity + specificity - 1) becomes the maximum value.
All statistical analyses were carried out using SPSS (ver. 23.0; 
IBM Corp., Armonk, NY, USA). All statistical tests were two-sided. 
Significance was fixed at the P = 0.05 level. 
RESULTS
General characteristics
In the NHNS in Japan (2008), 30,135 participants were identified 
using stratified random sampling, with 7,998 completing 
physical examinations, 4,451 completing blood tests, 9,129 
completing assessment of nutritional intake status, and 8,557 
completing assessment of daily living habits. The age distribu-
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Correlates
(Dependent variable: Serum albumin)
β P-value VIF
Sex (male: 1, female: 0) 0.143 0.004 1.167
Age (yrs) -0.005 0.004 1.289
Body mass index (kg/m2) -0.007 0.421 3.803
Mid-arm muscle area (cm2) 0.001 0.740 1.983
Calf circumference (cm) 0.017 0.015 2.797
Relative daily energy intake (kcal/kg) 0.007 0.010 1.551
Hemoglobin (g/dL) 0.076 < 0.001 1.418
Blood platelet count (× 103/μL) 0.013 < 0.001 1.253
HDL cholesterol (mg/dL) 0.008 < 0.001 1.248
LDL cholesterol (mg/dL) 0.001 0.054 1.299
HbA1c (%) 0.068 0.022 1.178
Log C-reactive protein (mg/dL) -0.163 < 0.001 1.351
Immunoglobulin G (mg/dL) < 0.001 0.348 1.195
Anticonvulsants and/or major tranquilizers -0.056 0.183 1.197
Onset of disability
(early stage: 1, adulthood and later: 0)
0.017 0.699 1.297
Facility 2 dummy1) -0.061 0.338 1.741
Facility 3 dummy1) -0.097 0.129 1.760
Facility 4 dummy1) -0.043 0.517 1.835
Facility 5 dummy1) -0.129 0.043 1.704
Adjusted R-square 0.49
HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density 
lipoprotein; VIF, variance inflation factor.
1) Facility 1: reference
Table 4. Correlates of serum albumin level on multivariable analyses among 249










Weight (kg) 0.23 Relative daily protein intake (g/kg) 0.25 HDL cholesterol (mg/dL) 0.42**
Body mass index (kg/m2) 0.27* White blood cells (× 103/μL) 0.25 LDL cholesterol (mg/dL) 0.29*
Weight change ratio for a month (%) 0.25 Red blood cells (× 106/μL) 0.26 Triglyceride (mg/dL) 0.27
Weight change ratio for 3 months (%) 0.24 Hemoglobin (g/dL) 0.42** HbA1c (%) 0.32**
Weight change ratio for 6 months (%) 0.26 Hematocrit (%) 0.43** C-reactive protein (mg/dL) -0.48**
Triceps skinfold thickness (mm) -0.27 Blood platelet count (× 103/μL) 0.36** (logarithmic transformation)
Mid-arm circumference (cm) 0.26 Total protein (g/dL) 0.62** Immunoglobulin G (mg/dL) 0.28*
Mid-arm muscle circumference (cm) 0.29* AST (GOT) (IU/L) 0.25 Anticonvulsants and/or major tranquilizers -0.31*
Mid-arm muscle area (cm2) 0.30* ALT (GPT) (IU/L) 0.26 Minor tranquilizers -0.25
Calf circumference (cm) 0.29* γ-GTP (IU/L) 0.25 Other medications1) -0.27
Relative daily energy intake (kcal/kg) 0.28* Total cholesterol (mg/dL) 0.39** Onset of disability 0.28
  (early stage:1, adulthood and later: 0)
ALT, alanine aminotransferase; AST, aspartate transaminase; GOT, glutamic-oxaloacetic transaminase; GPT, glutamic-pyruvate transaminase; HbA1c, glycated hemoglobin; HDL, 
high-density lipoprotein; LDL, low-density lipoprotein; γ-GTP, gamma-glutamyl transpeptidase. 
1) Medications other than anticonvulsants and/or major tranquilizers and minor tranquilizers (i.e., gastrointestinal drugs, drugs for the common cold, cardiovascular medication).
** P < 0.001, * P < 0.05.
Table 3. Sex- and age-adjusted analyses of serum albumin level among 249 individuals with motor disabilities at five institutions in Ibaraki, Japan
tions of those who completed the blood tests were as follows: 
20-29 years, n = 245; 30-39 years, n = 516; 40-49 years, n = 502; 
50-59 years, n = 794; 60-69 years, n = 1 108; and ≥ 70 years, 
n = 1,286. 
The sample included 144 men (mean age, 51.4 ± 12.2 years) 
and 105 women (mean age, 51.4 ± 12.3 years) (Table 1). A 
median 30 (range: 26-30) men and 20 (range: 18-25) women 
participated in each institution. The most common primary 
cause of MD was CP (n = 98), followed by cerebrovascular 
disease (n = 50) and brain contusion (n = 20). Early-stage MD 
onset was present in 101 (40.6%) individuals, and 148 (59.4%) 
individuals had MD onset in adulthood and later. In the present 
study, approximately 60% of individuals had mastication 
disorders and dysphagia, and the mean meal consumption rate 
was 89% (range: 30-100%). Among all target individuals (n =
249), eight (3.2%) had chronic kidney disease, 30 (12.0%) had 
liver disease, three (1.2%) had thyroid dysfunction, and 20 (8.0%) 
had bowel disease. Among the 42 individuals with 
hypoalbuminemia, no participants had any of these conditions.
Serum albumin levels
The mean serum albumin levels were 4.0 ± 0.4 g/dL for men 
and 3.8 ± 0.5 g/dL for women, which were lower than those 
in the NHNS for the same age cohort (4.5 ± 0.3 g/dL for men, 
4.5 ± 0.2 g/dL for women) (Table 2). When the SD of the serum 
albumin level in individuals with MD was converted to 0.5, the 
difference in means between healthy individuals in the NHNS 
and individuals with MD in the present study was 0.6, which 
was greater than the SD, indicating a large difference in mean 
serum albumin levels between these groups. Low serum 
albumin levels (≤ 3.5 g/dL) were present in 17 (11.8%) of the 
144 men and 25 (23.8%) of the 105 women. In the analyses 
by sex and age, compared with healthy individuals, low serum 
albumin levels were observed more frequently in all individuals 
with MD, with the exception of men aged ≥ 70 years and 
women aged 20-29 years. 
Correlates of the serum albumin level
Of the 33 variables investigated in the sex- and age-adjusted 
analyses, 16 were significantly correlated with serum albumin 
level, including CRP level, medication, and timing of disability 
onset (Table 3). 
In the multivariable analysis, subsequent factors were 
independently and significantly correlated with low serum 
albumin levels, including female sex, advanced age, low calf 
circumference, low relative daily energy intake, low Hb, low PLT, 
low HDL-C, low HbA1c, and high CRP levels (Table 4). Standardized 
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beta values showed that, among these factors, Hb had the 
strongest correlation (0.321), followed by CRP (-0.279) and 
HDL-C (0.279). The cut-off value in the ROC curve using the 
Youden index was 0.325. Considering the frequency of 
hypoalbuminemia using this cut-off value, 27 (31.0%) individuals 
exhibited high CRP levels (≥ 0.325 mg/dL) while 15 (9.3%) 
individuals exhibited normal CRP levels (< 0.325 mg/dL).
DISCUSSION
This study investigated serum albumin levels and their 
correlates as well as the effects of onset timing in institutio-
nalized individuals with MD and demonstrated that the 
prevalence of hypoalbuminemia was greater in both men and 
women with MD than in healthy individuals. Moreover, inflam-
mation was a strong negative correlate of serum albumin level, 
whereas MD onset timing did not affect serum albumin level. 
There was a large difference in mean serum albumin levels 
between healthy individuals and individuals with MD, as 
indicated by the conversion and comparison of the SD. In 
addition, hypoalbuminemia was observed in 11.8% of men and 
23.8% of women in the present sample, which were greater 
than the proportions of healthy individuals aged 50-59 years 
(0.3% of men, 0.2% of women) in the NHNS from the same 
time period. Several factors can reduce serum albumin levels, 
including insufficient protein intake. Due to mastication disorders 
and dysphagia, individuals with MD might not have sufficient 
food and calorie intake [3-7], which could augment degradation 
of body proteins and lead to reduced serum albumin levels. 
Moreover, the mean meal consumption rate was approximately 
9% lower in those with mastication disorders and dysphagia 
(approximately 86%) than in those without (approximately 
95%). However, all participants in this study received meal 
support as institutional residents; therefore, no differences in 
serum albumin level due to swallowing impairments (mastication 
disorders and dysphagia) were observed. 
Second, use of medications, particularly antiepileptic drugs, 
can decrease the capability to synthesize hepatic albumin, and 
use anticonvulsants and/or major tranquilizers and other 
medications has been associated with low serum albumin levels 
in men with ID [23]; 234 of 249 individuals (94%) in the present 
study were taking medications. Albumin is synthesized only in 
liver cells, and its production is quite constant in healthy 
individuals; therefore, just a small intracellular deposit of protein 
is needed [14]. However, although the negative correlation 
between serum albumin levels and use of medications was 
significant in the sex- and age-adjusted analyses in the present 
study, it was not significant in the multivariable analysis. 
The correlates of low serum albumin level in the present study 
included female sex, advanced age, low calf circumference, low 
relative daily energy intake, low Hb, low PLT, low HDL, low 
HbA1c, and high log CRP levels. The lower serum albumin level 
in women than in men in the present study might be explained 
by menopause and aging, which affect total serum albumin 
levels [41], particularly considering that 57 of the 105 women 
in the present study were older than 50 years. However, the 
mean serum albumin levels for both men (4.0 g/dL) and women 
(3.8 g/dL) in the present study were lower than those of the 
general Japanese population of similar age (50-59 years) in the 
NHNS (4.5 g/dL, men and women). 
Appropriate Hb, PLT, HDL-C, and HbA1c levels signify overall 
good nutritional status, and it is reasonable to assume that 
these factors are not direct causes of low serum albumin levels 
but rather share the same nutritional basis as serum albumin; 
however, the individual mechanisms remain unclear.
Appropriate dietary intake is important to maintain good 
nutritional status. When relative daily energy intake and relative 
daily protein intake were considered in the sex-age adjusted 
analyses, only relative daily energy intake was significantly 
correlated with serum albumin levels. This suggests that relative 
daily energy intake reflects albumin levels.
CRP is a sensitive marker of inflammation [42], and CRP levels 
were negatively associated with serum albumin in a number 
of studies [43-49]. In the present study, the negative correlation 
between CRP and serum albumin levels was significant in both 
the sex- and age-adjusted and multivariable analyses, similar 
to results from a previous study on individuals with ID [23]. 
A negative correlation with inflammation was also observed in 
individuals with MD. The cut-off value in the ROC curve using 
the Youden index was 0.325. The area under the curve was 
0.7, and the discernment was mostly favorable. The prevalence 
of hypoalbuminemia in those with high CRP levels was about 
three times more frequent as compared to those with normal 
CRP levels. Participants with hypoalbuminemia individuals may 
suffer from general malnutrition since 9% had normal CRP 
levels. Chronic inflammatory disease augments proteolysis in 
the body, thereby reducing the serum albumin level. In the 
current study, comorbid chronic inflammatory diseases of the 
digestive or respiratory system were observed in 50 individuals 
with lower mean serum albumin levels (3.4 ± 0.4 g/dL) 
compared to individuals without chronic inflammatory diseases 
(4.1 ± 0.4 g/dL), suggesting that low serum albumin levels may 
be due to the presence of chronic inflammatory diseases. 
Although the timing of MD onset was not significantly 
correlated with serum albumin levels in the sex- and age- 
adjusted analyses in the present study, the mean serum albumin 
level did not differ by timing of MD onset (3.96 g/dL in the 
early stage and 3.84 g/dL in adulthood and later). 
There were several limitations to this study. First, we 
compared our data to published data from the general 
population. Owing to missing details, the characteristics of the 
study population in the national survey could not be compared 
with those of the study population. Second, although height, 
current weight, subcutaneous fat thickness, and circumferences 
were measured using standard procedures, past weight was not; 
however, measurement conditions were generally consistent. At 
each facility, weight was normally measured prior to bathing 
with all clothes removed. Third, although the types and number 
of medications used at the time of this study were ascertained, 
it is possible that temporary medications such as cold medicines 
were included or that long-term medications ceased just before 
the study were not included. Fourth, the most common primary 
cause of MD was CP, followed by stroke and brain contusion. 
Despite diverse participant backgrounds, determination of the 
effects of MD on nutritional status was a priority in the present 
study, regardless of background. Finally, the individuals in the 
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present study were institutionalized and under controlled 
nutritional management; therefore, generalizing the findings to 
individuals with MD undergoing home-based care should be 
undertaken with caution.
The results of this study suggest that institutionalized 
individuals with MD have lower mean serum albumin levels and 
higher percentages of hypoalbuminemia than healthy individuals. 
The correlation assessments indicate that inflammation should 
be considered for patients with MD. In addition to inflammation, 
female sex, advanced age, low calf circumference, low relative 
daily energy intake, as well as low Hb, low PLT, low HDL-C, 
and low HbA1c levels appear to be correlated with low serum 
albumin levels. Regarding hypoalbuminemia in institutionalized 
individuals with MD, women should receive particular conside-
ration. Using the present study as a guideline, further research 
is necessary to analyze the association between serum albumin 
levels and prognosis.
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